<Anchor> We will
continue to look at the flu vaccine problem.
In order to prevent the vaccine from being exposed to room temperature again during the distribution process, there are many voices that the overall delivery management system must be supplemented.
The analysis says that the lack of specific management regulations for temperature-sensitive vaccines is the root cause of this incident.
This is reporter Kim Hyung-rae.
<Reporter>
Health authorities are known to conduct safety and efficacy tests on 750 doses, 0.015% of the 5 million flu vaccine doses that may have been exposed to room temperature from the day before (22nd).
However, it was not disclosed by what criteria the vaccine was selected.
Officials from the quarantine authorities have stated that they are discussing ways to sample each delivery truck carrying the flu vaccine or by the medical institution where the vaccine was last delivered.
Shinsung Pharm, which caused the national vaccinations to stop, claimed that there were 170,000 vaccines exposed to room temperature, but SBS reports confirmed that the health authorities have not yet secured all temperature records for delivery vehicles.
The problem is that the authorities' delivery regulations for refrigerated injections are poor.
The United States meticulously stipulates specific requirements for transport vehicles, drivers, refrigerants, and boxes.
Taiwan requires health center professionals to deliver vaccines directly.
However, in Korea, there are some regulations on the box, but there are no specific compliance requirements.
There is also a lack of professional training for transport staff.
[Pharmaceutical company officials: It is difficult to keep the door open while (staff) delivery or to maintain a certain temperature.] The
health authorities will announce the results of the first on-site investigation of Shinsung Pharmaceutical tomorrow.
(Video coverage: Lee Yong, video editing: Lee Seung-hee)